T CELL MALIGNANCIES
Clinical trials for T CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new T CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for T CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough blood cancers: first human trial begins
Disease control Recruiting nowThis is the first human study of an experimental drug called ELA026 for adults with T cell or NK cell cancers that have returned or stopped responding to other treatments. The study aims to find safe doses and see if the drug can help control the cancer. It will enroll about 84 p…
Matched conditions: T CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: Electra Therapeutics Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New immune cell therapy targets aggressive blood cancers in kids and adults
Disease control Recruiting nowThis study is testing a new type of personalized immune cell therapy called CD7 CAR T-cells for patients with T-cell blood cancers that have returned or not responded to other treatments. The therapy involves collecting a patient's own immune cells or using donor cells, modifying…
Matched conditions: T CELL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New 'Living Drug' trial targets aggressive blood cancers in kids and adults
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy called CD5 CAR-T for people with T-cell cancers that have come back or not responded to other treatments. Doctors will modify a patient's own immune cells (or cells from a donor) to better target and fight the cancer. …
Matched conditions: T CELL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for incurable blood cancers: experimental CAR-T therapy enters trial
Disease control Recruiting nowThis study is testing a new type of personalized immune cell therapy, called CD5-CAR T cells, for people with aggressive T-cell blood cancers that have come back or not responded to standard treatments. The main goals are to find a safe and effective dose and to see if the therap…
Matched conditions: T CELL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC